Ensysce Biosciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Ensysce Biosciences is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.90. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 515.03K	$ 435.38K	$ 490.47K	$ 789.63K	$ 1.43M
Gross Profit	$ 515.03K	$ 435.38K	$ 490.47K	$ 789.63K	$ 2.75M
EBIT	$ -3.16M	$ -2.68M	$ -2.24M	$ 4.51M	$ -6.23M
EBITDA	$ -2.83M	$ -2.68M	$ -2.24M	$ 4.51M	$ -6.23M
Net Income Common Stockholders	$ -3.50M	$ -2.69M	$ -2.24M	$ 4.51M	$ -5.52M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.12M	$ 1.46M	$ 3.83M	$ 1.42M	$ 3.15M
Total Assets	$ 2.71M	$ 3.22M	$ 6.36M	$ 3.91M	$ 5.89M
Total Debt	$ 854.70K	$ 353.66K	$ 456.66K	$ 19.12K	$ 4.74M
Net Debt	$ -268.91K	$ -1.11M	$ -3.37M	$ -1.40M	$ 1.60M
Total Liabilities	$ 3.36M	$ 2.06M	$ 2.56M	$ 4.07M	$ 9.91M
Stockholders Equity	$ -322.86K	$ 1.49M	$ 4.08M	$ 166.72K	$ -3.71M
Cash Flow	-
Free Cash Flow	$ -1.80M	$ -2.26M	$ -3.11M	$ -3.61M	$ -3.30M
Operating Cash Flow	$ -1.80M	$ -2.26M	$ -3.11M	$ -3.61M	$ -3.30M
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 1.46M	$ -102.45K	$ 5.52M	$ 1.87M	$ 1.94M

Currency in USD

Ensysce Biosciences Earnings and Revenue History

Income Statement >

Ensysce Biosciences Debt to Assets

Balance Sheet >

Ensysce Biosciences Cash Flow

Cash Flow >

Ensysce Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing